067080 Stock Chart & Stats
₩7870.00
-₩660.00(-7.74%)
―
--
Day’s Range― - ―
52-Week Range₩7,690.00 - ₩24,900.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)141.82K
Market Cap
₩158.88B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)87.0
Beta0.35
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding18,616,650
10 Day Avg. Volume223,788
30 Day Avg. Volume141,818
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
067080 FAQ
What was DAE HWA PHARM Co., Ltd.’s price range in the past 12 months?
DAE HWA PHARM Co., Ltd. lowest stock price was ₩7690.00 and its highest was ₩24900.00 in the past 12 months.
What is DAE HWA PHARM Co., Ltd.’s market cap?
DAE HWA PHARM Co., Ltd.’s market cap is ₩158.88B.
When is DAE HWA PHARM Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were DAE HWA PHARM Co., Ltd.’s earnings last quarter?
DAE HWA PHARM Co., Ltd. released its earnings results on May 15, 2026. The company reported -₩13.685 earnings per share for the quarter, missing the consensus estimate of N/A by -₩13.685.
Is DAE HWA PHARM Co., Ltd. overvalued?
According to Wall Street analysts DAE HWA PHARM Co., Ltd.’s price is currently Undervalued.
Does DAE HWA PHARM Co., Ltd. pay dividends?
DAE HWA PHARM Co., Ltd. does not currently pay dividends.
What is DAE HWA PHARM Co., Ltd.’s EPS estimate?
DAE HWA PHARM Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does DAE HWA PHARM Co., Ltd. have?
DAE HWA PHARM Co., Ltd. has 18,616,650 shares outstanding.
What happened to DAE HWA PHARM Co., Ltd.’s price movement after its last earnings report?
DAE HWA PHARM Co., Ltd. reported an EPS of -₩13.685 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.774%.
Which hedge fund is a major shareholder of DAE HWA PHARM Co., Ltd.?
Currently, no hedge funds are holding shares in KR:067080
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Daewon Pharmaceutical Co., Ltd
―
Daihan Pharmaceutical Co., Ltd.
―
Reyon Pharmaceutical Co., Ltd.
―
Jeil Pharmaceutical Co. Ltd.
―
Hana Pharm Co., Ltd.
―